Han, R.; Sun, D.; Li, S.; Chen, J.; Teng, M.; Yang, B.; Dong, Y.; Wang, T.
Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients. Antibiotics 2021, 10, 993.
https://doi.org/10.3390/antibiotics10080993
AMA Style
Han R, Sun D, Li S, Chen J, Teng M, Yang B, Dong Y, Wang T.
Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients. Antibiotics. 2021; 10(8):993.
https://doi.org/10.3390/antibiotics10080993
Chicago/Turabian Style
Han, Ruiying, Dan Sun, Sihan Li, Jiaojiao Chen, Mengmeng Teng, Bo Yang, Yalin Dong, and Taotao Wang.
2021. "Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients" Antibiotics 10, no. 8: 993.
https://doi.org/10.3390/antibiotics10080993
APA Style
Han, R., Sun, D., Li, S., Chen, J., Teng, M., Yang, B., Dong, Y., & Wang, T.
(2021). Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients. Antibiotics, 10(8), 993.
https://doi.org/10.3390/antibiotics10080993
